UnitedHealthcare
Inbrija (levodopa)
Drugs for the Nervous System : Drugs for Parkinson
  • Step Therapy: Parkinson's Disease:
    ST Multiple Generics

  • Quantity Limit: limit maximum 10 EA PER 1 day(s)
  • Prior Authorization: Parkinson's Disease:
    Documented Diagnosis: Yes
    Duration: 6 Month(s)
    Reauthorization Required: Yes

  • Parkinson's Disease:
    Duration: 6 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): 1 of Appropriate Specialist;Neurologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Diagnosis Type(s): Unspecified
    Clinically documented acute, intermittent treatment of hypomobility "off" episodes: Yes
    Concomitant Use of Max Tolerable Dose of levodopa + 1 selegiline,pramipexole,entacapone,rasagiline: No
    Use as adjunct therapy: No
    Requires concomitant anti-emetic agent: No
    Supporting Documentation Requirements: Chart Notes